Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Presence of Foreign Tablets/Capsules.
Failed Dissolution Specifications - low dissolution results
Chemical Contamination: Presence of benzene.
Presence of foreign tablets/capsules
Why this is here: It was found to contain a drug or chemical that is not on the label. That is different from an allergen or a contamination scare: anyone taking it has been taking a substance nobody prescribed, in an unknown dose, and it can interact with medication they are already on. Follow the agency notice rather than judging it by how the product looks.
Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
Presence of Particulate Matter
Lack of Assurance of Sterility: due to a quality control process deviation
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Subpotent Drug
Subpotent Drug
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Non-Sterility: contamination of Aspergillus penicillioides, due to breach in package lidding.
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Labeling: Label Error on Declared Strength.